Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
Abstract Interest in understanding the high chemoresistance and poor prognosis of advanced ovarian clear cell carcinoma (OCCC) is rising. Patient-derived xenografts (PDX) are widely used in vivo models because of their supposedly accurate morphologic and (epi)genetic representation of patient tumors...
Saved in:
Main Authors: | Joseph J. Caumanns, Shang Li, Gert J. Meersma, Evelien W. Duiker, Ate G. J. van der Zee, G. Bea A. Wisman, Steven de Jong |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-86384-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Validity of patient-derived xenograft mouse models for lung cancer based on exome sequencing data
by: Jaewon Kim, et al.
Published: (2020-03-01) -
Development and characterization of orthotopic patient-derived xenograft models of peritoneal metastatic mucinous appendiceal adenocarcinoma
by: I. Ito, et al.
Published: (2025-03-01) -
Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer
by: Wei Chen, et al.
Published: (2025-01-01) -
Comparison of the Genetic Alterations between Primary Colorectal Cancers and Their Corresponding Patient-Derived Xenograft Tissues
by: Sang Mi Yu, et al.
Published: (2018-06-01) -
Promising Remission with Reduced Bevacizumab and Pembrolizumab Dosage in a Patient with AT-rich Interaction Domain 1A Mutated Ovarian Clear-cell Carcinoma Refractory to Chemotherapy
by: Cheng-Wei Huang, et al.
Published: (2024-01-01)